140 related articles for article (PubMed ID: 14993814)
1. Studies on the intestinal absorption of low molecular weight heparin using saturated fatty acids and their derivatives as an absorption enhancer in rats.
Mori S; Matsuura A; Rama Prasad YV; Takada K
Biol Pharm Bull; 2004 Mar; 27(3):418-21. PubMed ID: 14993814
[TBL] [Abstract][Full Text] [Related]
2. In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer.
Rama Prasad YV; Minamimoto T; Yoshikawa Y; Shibata N; Mori S; Matsuura A; Takada K
Int J Pharm; 2004 Mar; 271(1-2):225-32. PubMed ID: 15129989
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption of low molecular weight heparin in animals and human subjects.
Nissan A; Ziv E; Kidron M; Bar-On H; Friedman G; Hyam E; Eldor A
Haemostasis; 2000; 30(5):225-32. PubMed ID: 11251329
[TBL] [Abstract][Full Text] [Related]
4. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
5. [Oral cavity delivery system of unfractionated and low molecular weight heparin].
Li D; Hou HM
Yao Xue Xue Bao; 2010 Oct; 45(10):1317-21. PubMed ID: 21348313
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol 934P.
Thanou M; Verhoef JC; Nihot MT; Verheijden JH; Junginger HE
Pharm Res; 2001 Nov; 18(11):1638-41. PubMed ID: 11758776
[No Abstract] [Full Text] [Related]
7. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies.
Ito Y; Kusawake T; Prasad YV; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Jul; 317(2):114-9. PubMed ID: 16631328
[TBL] [Abstract][Full Text] [Related]
8. Nasal administration of low molecular weight heparin.
Arnold J; Ahsan F; Meezan E; Pillion DJ
J Pharm Sci; 2002 Jul; 91(7):1707-14. PubMed ID: 12115833
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant effects of low-molecular-weight heparins in healthy cats.
Alwood AJ; Downend AB; Brooks MB; Slensky KA; Fox JA; Simpson SA; Waddell LS; Baumgardner JE; Otto CM
J Vet Intern Med; 2007; 21(3):378-87. PubMed ID: 17552440
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent.
Lee Y; Nam JH; Shin HC; Byun Y
Circulation; 2001 Dec; 104(25):3116-20. PubMed ID: 11748110
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.
Lee YK; Kim SK; Lee DY; Lee S; Kim CY; Shin HC; Moon HT; Byun Y
J Control Release; 2006 Apr; 111(3):290-8. PubMed ID: 16497407
[TBL] [Abstract][Full Text] [Related]
12. Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats.
Zhang H; Mi J; Huo Y; Huang X; Xing J; Yamamoto A; Gao Y
Int J Pharm; 2014 May; 466(1-2):156-62. PubMed ID: 24614577
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats.
Ito Y; Murakami A; Maeda T; Sugioka N; Takada K
Int J Pharm; 2008 Feb; 349(1-2):124-9. PubMed ID: 17826015
[TBL] [Abstract][Full Text] [Related]
14. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin.
Yang T; Hussain A; Bai S; Khalil IA; Harashima H; Ahsan F
J Control Release; 2006 Oct; 115(3):289-97. PubMed ID: 17023085
[TBL] [Abstract][Full Text] [Related]
15. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.
Kim SK; Lee EH; Vaishali B; Lee S; Lee YK; Kim CY; Moon HT; Byun Y
J Control Release; 2005 Jun; 105(1-2):32-42. PubMed ID: 15925422
[TBL] [Abstract][Full Text] [Related]
16. Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
J Pharm Pharmacol; 2006 May; 58(5):591-8. PubMed ID: 16640827
[TBL] [Abstract][Full Text] [Related]
17. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
[TBL] [Abstract][Full Text] [Related]
18. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
19. Gastro-intestinal patch system for the delivery of erythropoietin.
Venkatesan N; Uchino K; Amagase K; Ito Y; Shibata N; Takada K
J Control Release; 2006 Mar; 111(1-2):19-26. PubMed ID: 16377018
[TBL] [Abstract][Full Text] [Related]
20. Intraduodenal absorption in the rabbit of a novel heparin salt.
Andriuoli G; Caramazza I; Galimberti G; Zoppetti G; Benedini F; Sala A; Del Soldato P
Haemostasis; 1992; 22(3):113-6. PubMed ID: 1330852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
